NCT00004080View on ClinicalTrials.gov

Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

recombinant adenovirus-p53 SCH-58500

PROCEDURE

conventional surgery

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004080 - Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors | Biotech Hunter | Biotech Hunter